Treatment outcome in patients with triple negative early stage breast cancers compared with other molecular subtypes

PURPOSE: To determine whether triple negative (TN) early stage breast cancers have poorer survival rates compared with other molecular types. MATERIALS AND METHODS: Between August 2000 and July 2006, patients diagnosed with stage I, II early stage breast cancers, in whom all three markers (estrogen...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Ja Young, Chang, Sei-Kyung, Park, Heily, Lee, Bo-Mi, Shin, Hyun Soo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society for Radiation Oncology 2012
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3496846/
https://www.ncbi.nlm.nih.gov/pubmed/23170291
http://dx.doi.org/10.3857/roj.2012.30.3.124

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3496846/
https://www.ncbi.nlm.nih.gov/pubmed/23170291
http://dx.doi.org/10.3857/roj.2012.30.3.124

Ejemplares similares